How to Troubleshoot Abnormal Impurities in Peptide Synthesis? Locating Process Issues Through Amino-Related Side Reactions

Introduction

Abnormal impurities in peptide synthesis are usually not caused by a single factor. Instead, they often result from the combined effects of sequence characteristics, protecting-group strategy, reagent condition, washing efficiency, and post-treatment conditions. In solid-phase peptide synthesis (SPPS), amino groups are not only the key reactive sites for peptide-chain elongation, but also important sources of non-target acylation, alkylation, and capping side reactions. Starting from amino-related side reactions, this article discusses source identification, experimental-step localization, interpretation of analytical signals, and process optimization strategies for abnormal impurities, helping laboratory personnel establish a clear and executable troubleshooting approach.

1. Why Amino Groups Should Be the First Focus When Investigating Abnormal Impurities

1.1 Free amino groups are the core reactive sites for peptide-chain elongation

The essence of peptide synthesis is the formation of an amide bond between an amino group and an activated carboxyl group. In 9-fluorenylmethoxycarbonyl solid-phase peptide synthesis, or Fmoc-SPPS, each amino acid elongation step usually involves Fmoc deprotection, washing, coupling, and further washing. The free N-terminal amino group generated after deprotection is the necessary reactive site for the next coupling reaction.

Free amino groups are relatively strong nucleophiles. In addition to reacting with the activated carboxyl group of the target amino acid, they may also react with other electrophilic species in the system. For example, acetic anhydride, residual activated esters, protecting-group cleavage products, certain aldehyde impurities, or solvent degradation products may react with free amino groups under specific conditions, resulting in non-target modifications.

Therefore, when abnormal peaks appear in high-performance liquid chromatography (HPLC) chromatograms, or when liquid chromatography–mass spectrometry (LC-MS) shows abnormal mass shifts, amino-related side reactions should be considered an important troubleshooting direction.

1.2 Amino-related side reactions usually appear as three types of problems

In final analytical results, amino-related side reactions usually appear as the following three types of problems:

Abnormality type	Possible manifestation	Common impact
Non-target acylation	Acetylation, formylation, or other acylation-related mass increases	Reduced target peptide purity and formation of difficult-to-separate impurities
Non-target alkylation	N-alkylation or adducts related to protecting-group cleavage	Formation of newly modified peptides and more difficult MS interpretation
Non-target capping	N-terminus becomes blocked and the peptide chain cannot continue to elongate	Formation of truncated or deletion peptides

2. Locating the Source of Impurities by Experimental Step

2.1 Coupling stage: focus on deletion peptides and incomplete reactions

The purpose of the coupling stage is to allow the free amino groups on the resin to react with the activated carboxyl group of the amino acid. If coupling is incomplete, the unreacted amino groups may continue to participate in side reactions during subsequent steps, forming deletion peptides, truncated peptides, or capped impurities. During the coupling stage, the following points should be checked carefully:

Troubleshooting item	Key question
Amino acid raw material	Is the purity insufficient? Has it absorbed moisture or degraded?
Coupling reagent and additive	Are they suitable for this sequence and specific site?
Type and amount of base	Does it affect activation efficiency or increase side reactions?
Coupling time	Is it too short or too long?
Resin swelling state	Does it affect reaction uniformity?
Sequence characteristics	Are there sterically hindered or aggregation-prone segments?

If LC-MS shows an impurity corresponding to the loss of one amino acid residue, the coupling efficiency at the corresponding site should be checked first. For sterically hindered residues such as valine (Val), isoleucine (Ile), tert-leucine (Tle), or 2-aminoisobutyric acid (Aib), double coupling, extended coupling time, or a different coupling system may be used when necessary.

2.2 Capping stage: focus on non-target acetylation

Capping is commonly used to treat free amino groups that failed to couple, preventing them from participating in subsequent chain elongation. Common capping reagents include acylating reagents such as acetic anhydride. Proper capping can reduce the formation of complex impurities caused by continued elongation of deletion sequences, but poorly controlled capping conditions may also introduce non-target acetylation. Two situations should be clearly distinguished:

Situation	Key point for judgment
Designed N-terminal acetylation	A target structural modification
Non-target acetylation	A process-related impurity whose source needs to be investigated

Non-target acetylation may originate from the following steps or conditions:

① Excessive capping reagent or excessively long reaction time;

② Insufficient washing after capping;

③ After failed coupling in the previous step, the unreacted amino group is capped;

④ Improper selection or use of the lysine (Lys) side-chain protecting group, abnormal deprotection of the protecting group, or the presence of unprotected/insufficiently protected impurities in the raw material;

⑤ Residual acetylation-active substances entering subsequent steps.

If an acetylated truncated peptide is detected, it should not simply be regarded as an impurity “caused by capping.” A more accurate interpretation is that incomplete coupling may already have occurred before capping; capping merely fixed the unelongated amino group as an acetylated terminated structure.

2.3 Deprotection stage: focus on incomplete deprotection and byproduct residues

In Fmoc-SPPS, the Fmoc group is typically removed using basic reagents such as piperidine. This process generates a highly reactive dibenzofulvene (DBF) intermediate. Under normal conditions, DBF is captured by an excess of secondary amines such as piperidine, forming a relatively stable adduct. If the deprotection solution condition, treatment time, diffusion inside the resin, or washing efficiency is poor, incomplete deprotection, DBF-related residue/adduct risks, or byproduct residues may occur. During the deprotection stage, two main issues should be considered:

Issue	Possible result
Incomplete deprotection	Failure of subsequent coupling, leading to deletion peptides
Byproduct residues	Increased risk of non-target adduct formation or alkylation

For long peptides, hydrophobic peptides, or aggregation-prone sequences, restricted diffusion inside the resin may reduce deprotection and washing efficiency. In such cases, simply extending the deprotection time is not sufficient. It is also necessary to improve washing efficiency, optimize the solvent system, or adjust the resin loading.

2.4 Cleavage and global deprotection stage: focus on acid-treatment side reactions

After Fmoc-SPPS is completed, trifluoroacetic acid (TFA) systems are commonly used to cleave the peptide from the resin while simultaneously removing most acid-sensitive side-chain protecting groups. TFA cleavage cocktails often contain scavengers such as water, triisopropylsilane (TIS), and ethanedithiol (EDT) to capture reactive intermediates generated during the reaction. Common risks at this stage include:

① Degradation of sensitive sequences caused by excessively long acid-treatment time;

② Inappropriate scavenger combination, resulting in insufficient capture of reactive intermediates;

③ Side reactions involving residues such as tryptophan (Trp), cysteine (Cys), and methionine (Met);

④ Increased downstream changes due to delayed precipitation, washing, or drying after cleavage.

2.5 Purification and post-treatment stage: focus on changes in the impurity profile

Reversed-phase high-performance liquid chromatography (RP-HPLC) is commonly used for peptide purification. TFA, formic acid, or acetic acid is often added to the mobile phase to improve peak shape and separation performance. For most peptides, these conditions are routine and effective. However, for certain sensitive sequences, prolonged exposure to acidic conditions, repeated freeze–thaw cycles, concentration/drying, or high-temperature treatment may alter the impurity profile.

If the crude peptide profile is acceptable but impurities increase after purification or storage, the following points should be checked first:

① Whether the sample solution remained under acidic conditions for a long time;

② Whether collected fractions were lyophilized promptly;

③ Whether the concentration temperature was too high;

④ Whether the sample underwent repeated freeze–thaw cycles;

⑤ Whether the acidic additive in the analytical method is suitable for the sequence.

3. Inferring the Type of Side Reaction from Abnormal Signals

3.1 Truncated peptides: prioritize coupling, deprotection, and capping

Truncated peptides usually appear as target peptides missing one or more amino acid residues. Their main sources include:

① Incomplete coupling at a certain step;

② Incomplete Fmoc deprotection in the previous step;

③ Capping of uncoupled amino groups;

④ Non-target acylation at the N-terminus, causing termination of chain elongation.

The following troubleshooting sequence is recommended:

Troubleshooting sequence	Key focus
Step 1	Check whether the missing site is sterically hindered or located in an aggregation-prone segment
Step 2	Check whether sufficiently strong coupling conditions were used at that site
Step 3	Check whether the previous deprotection step was complete
Step 4	Determine whether the truncated peptide carries a capping modification such as acetylation
Step 5	Verify through small-scale repeat synthesis when necessary

If the truncated peptide also shows an acetylation-related mass shift, the “incomplete coupling + capping” pathway should be checked first.

3.2 Acylation-related mass increases: distinguish acetylation, formylation, and trifluoroacetylation

Acylation-related impurities are relatively common among amino-related side reactions. Different types of acylation correspond to different troubleshooting directions.

Suspected modification	Possible source	Priority checks
Acetylation	Acetic anhydride capping, acetyl chloride or other activated acetylating species, residual capping reagent	Capping conditions, washing efficiency, N-terminal/Lys side-chain localization
Formylation	Dimethylamine/formic acid generated from aged DMF may indicate solvent-related risk; formylation generally needs to be judged together with formic acid exposure, activation/dehydration conditions, concentration/drying, or prolonged storage	DMF freshness, formic acid use, activation system, temperature, storage time, MS/MS localization
Trifluoroacetylation	Should not be attributed solely to ordinary TFA cleavage; resin/linker, trifluoroacetic anhydride (TFAA) or other activated trifluoroacetylation sources, contamination, or previous processing conditions should be investigated	Resin and linker, exposure to TFAA/trifluoroacetylation reagents, cleavage system, MS/MS localization

Among these, N,N-dimethylformamide (DMF) requires special attention. Long-term exposure of DMF to air and moisture may generate dimethylamine and formic acid. Dimethylamine can cause unintended removal of Fmoc protecting groups, affecting resin loading or subsequent synthesis quality. If formylation is suspected, it should be evaluated together with formic acid use, activators/dehydration conditions, sample concentration/drying, temperature, and storage time. It should not be directly assigned as a formylation source solely because DMF or formic acid was used.

3.3 N-alkylation-related impurities: prioritize deprotection byproducts and scavengers

N-alkylation is a side reaction formed when free amino groups react with alkylating substances. Possible sources include protecting-group cleavage products, aldehyde impurities, reactive species related to resin linkers, or reaction intermediates in the deprotection system. Common troubleshooting directions include:

① Whether the Fmoc deprotection solution is fresh;

② Whether the piperidine concentration and treatment time are appropriate;

③ Whether DBF is sufficiently captured by an excess of secondary amines such as piperidine under normal deprotection conditions;

④ Whether washing after deprotection is sufficient;

⑤ Whether sufficient scavenger is used during allyloxycarbonyl (Alloc) deprotection;

⑥ Whether aldehydes or other reactive alkylating substances are present in the reaction system.

It should be noted that under normal piperidine deprotection conditions, DBF is mainly captured to form amine adducts. When capture is insufficient, diffusion is restricted, residence time is abnormal, or washing is inadequate, DBF-related adduct risks should be given priority consideration.

3.4 Significant batch-to-batch impurity differences: prioritize solvents, reagents, and operational consistency

If the impurity profiles of the same sequence differ significantly between batches, process consistency should be investigated first, rather than immediately modifying the entire synthetic route. Key variables include:

Variable	Possible impact
DMF freshness	Affects Fmoc stability and formylation-related risk
TFA batch and water content	Affects cleavage and side-chain deprotection performance
Piperidine solution preparation time	Affects deprotection efficiency
Storage condition of coupling reagent	Affects coupling efficiency
Number and volume of washes	Affects removal of residual reagents
Residence time in the automated synthesis program	Affects exposure time of free amino groups

Batch differences usually arise from the accumulation of multiple small variables. Accurate recording of reagent batch numbers, opening dates, solution preparation times, and durations of key steps helps identify problems quickly.

4. Three Easily Overlooked Sources

4.1 Solvent condition may change the synthesis outcome

DMF is often regarded as a routine solvent, but it is not an inert background material that can remain stable indefinitely. Long-term storage, repeated opening, and exposure to air and moisture may all cause DMF quality to decline. For long peptides, difficult-to-couple sequences, or sequences sensitive to side reactions, the freshness of DMF is no less important than the choice of coupling reagent.

4.2 Washing efficiency determines whether residual reagents enter the next step

Many amino-related side reactions are not caused by the main reaction itself, but by active substances from the previous step being carried into the next step. Insufficient washing can significantly increase the risk of side reactions, especially when resin swelling is inadequate, the sequence is highly hydrophobic, or the resin loading is high. Key washing points include:

① After Fmoc deprotection;

② After coupling;

③ After capping;

④ During resin pre-treatment before cleavage;

⑤ After use of special protecting groups or metal-catalyzed deprotection.

Washing should not be performed merely as a fixed routine. Instead, it should be adjusted according to sequence difficulty, resin properties, and the risk of reagent carryover.

4.3 Sensitive sites in the sequence can amplify side-reaction risks

Peptide synthesis is strongly sequence-dependent. The same synthetic method may produce completely different impurity profiles for different sequences. The following residues require special attention:

Residue	Key risk
Lys	Acylation after abnormal exposure of the side-chain amino group; abnormalities in raw materials or protecting-group strategy
Trp	Acid treatment, protecting-group residues, and oxidation-related side reactions
Cys	Oxidation, alkylation, and incorrect disulfide pairing
Met	Oxidation
Ser/Thr	O-acylation and O→N acyl migration risk
Asp	Aspartimide formation and isomerization
Asn/Gln	Deamidation

Among these, Met oxidation, Asn/Gln deamidation, and Asp-related isomerization are not typical amino-related side reactions, but in practical impurity investigations they often appear together with amino-related side reactions.

5. Recommended Troubleshooting Workflow

5.1 First confirm whether the abnormal peak is a peptide-related impurity

The first step is not to directly assign a side reaction, but to confirm whether the abnormal peak originates from the peptide itself. The following checks are recommended:

① Whether the same peak appears in a blank injection;

② Whether the peak appears in both crude peptide HPLC and LC-MS;

③ Whether the target peak and impurity peak have reasonable UV absorbance;

④ Whether the impurity peak has a clear peptide-related molecular mass;

⑤ Whether the abnormal peak remains after changing the mobile phase or chromatographic conditions.

If the abnormal peak does not have a clear peptide-related mass, salts, solvents, plasticizers, buffer salt residues, or instrument background should be excluded first.

5.2 Then use mass shifts to narrow the range of possible side reactions

The mass shifts provided by LC-MS can be used for preliminary identification of modification types, but they should not be used as the sole basis for final assignment. For critical impurities, MS/MS should be used to localize the modification site. Common interpretation directions are as follows:

Mass-shift clue	Possible direction
Loss of one or more amino acid residues	Deletion peptide or truncated peptide
Acylation-related mass increase	Acetylation, formylation, or other acylation modification
Suspected trifluoroacetylation-related mass increase	Resin/linker, TFAA or other activated trifluoroacetylation source, or special acid-treatment conditions; further confirmation required
Alkylation-related mass increase	Protecting-group cleavage products, aldehydes, or other alkylating substances
Oxidation-related mass increase	Oxidation of residues such as Met, Trp, or Cys
Deamidation-related mass change	Asn, Gln, or storage-condition-related changes

5.3 Finally, combine the mass information with synthesis records to locate the step

Mass information must be correlated with synthesis records in order to determine the impurity source. The following sequence is recommended:

① What is the mass shift corresponding to the impurity?

② Which type of functional group could this modification occur on?

③ Does the sequence contain corresponding high-risk sites?

④ Which step in the synthesis is most likely to provide the reaction conditions?

⑤ Is there any reagent carryover, insufficient washing, or overly long treatment time?

⑥ Is small-scale control synthesis needed for verification?

Example judgments:

① If an acetylated truncated peptide appears, incomplete coupling and the capping step should be checked first;

② If a formylation-related modification appears, DMF condition, formic acid use, and the activation system should be checked first;

③ If an N-alkylation-related impurity appears, deprotection byproduct scavenging and washing should be checked first;

④ If impurities increase after purification, the acidic mobile phase, holding time, and lyophilization process should be checked first.

6. Process Recommendations for Reducing the Risk of Amino-Related Side Reactions

6.1 Conduct sequence risk assessment before synthesis

Before synthesis, the sequence length, hydrophobicity, sterically hindered residues, distribution of charged residues, and sensitive residues should be analyzed. For long peptides, hydrophobic peptides, or sequences with a strong tendency to aggregate, the following should be considered in advance:

① Whether to reduce resin loading;

② Whether to use double coupling;

③ Whether to use a more suitable coupling reagent;

④ Whether the protecting-group strategy needs to be changed;

⑤ Whether the cleavage system and scavenger combination need to be optimized.

Sequence risk assessment can reduce blind optimization later and improve the efficiency of problem localization.

6.2 Control the exposure time of free amino groups

Free amino groups are necessary intermediates for peptide-chain elongation, but prolonged exposure increases the probability of side reactions. Especially after deprotection, before capping, or when washing is insufficient, free amino groups are more likely to contact residual reactive substances. The following practices are recommended:

① Wash promptly after deprotection;

② Proceed to coupling as soon as possible after washing;

③ Avoid soaking the resin in the deprotection solution for an extended period;

④ Reduce unnecessary residence time in automated synthesis programs;

⑤ For difficult sequences, optimize washing volume and number of washing cycles.

6.3 Manage key reagents and solvents

Peptide synthesis is sensitive to reagent condition, especially DMF, TFA, piperidine, coupling reagents, bases, acetic anhydride, and scavengers. It is recommended to establish a basic reagent management table.

Reagent or solvent	Information to record
DMF	Opening date, storage conditions, use period
TFA	Batch number, opening time, water content
Piperidine solution	Preparation time, concentration, number of uses
Coupling reagent	Batch number, storage temperature, expiration date
Acetic anhydride	Amount used, reaction time, washing after capping
Scavenger	Ratio, expiration date, whether deterioration has occurred

6.4 Establish an abnormal-impurity record table

Peptide synthesis problems have clear value for accumulated experience. After each abnormal-impurity analysis, the following information should be recorded:

① Peptide sequence;

② Resin type and loading;

③ Amino acid protecting groups;

④ Coupling reagents and additives;

⑤ Deprotection conditions;

⑥ Whether capping was performed;

⑦ Cleavage system and time;

⑧ Crude peptide HPLC purity;

⑨ Major impurity masses by LC-MS;

⑩ Purification conditions.

7. Classification Table of Representative Chemicals Related to Troubleshooting Abnormal Impurities in Peptide Synthesis

Table 1. Synthesis Solvents, Precipitation/Washing Reagents, and Purification-Related Reagents

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Synthesis solvent	68-12-2	D119450	N,N-Dimethylformamide (DMF)	Anhydrous, ≥99.8%	Used for resin swelling and dissolution of amino acids and coupling reagents; freshness is relevant to troubleshooting formylation, abnormal deprotection, and batch-to-batch variation.
Synthesis solvent	872-50-4	M119668	N-Methyl-2-pyrrolidone (NMP)	Anhydrous, ≥99.5%	Used for resin swelling and reaction dissolution in solid-phase peptide synthesis; suitable for evaluating the effect of solvent switching on coupling efficiency and impurity profiles.
Synthesis solvent	75-09-2	D116155	Dichloromethane	Extra-dry, H₂O ≤0.004%, contains 50–150 ppm isopentene as stabilizer	Used for resin washing, swelling, and certain protecting-group treatments; water-content control is relevant to resin condition and side-reaction troubleshooting.
Synthesis solvent	67-68-5	D103274	Dimethyl sulfoxide (DMSO)	≥99.8% (GC)	Used for poorly soluble peptides, sulfur-containing sequences, and special dissolution systems; relevant to monitoring oxidative byproducts and sample stability.
Purification solvent	75-05-8	A119013	Anhydrous acetonitrile (ACN)	≥99.8%, H₂O ≤0.005%	Used for reversed-phase liquid chromatography analysis and preparative purification; relevant to abnormal peak separation, retention behavior, and monitoring impurity changes after purification.
Purification solvent	67-56-1	M116120	Methanol	≥99.9% (GC)	Used for sample dissolution, washing, and analytical method development; suitable for comparing the effects of solvent systems on peptide solubility and impurity peak shape.
Purification medium	7732-18-5	W433895	Water	Suitable for analysis, premium grade	Used in liquid chromatography mobile phases, cleavage-system scavengers, and sample reconstitution; water quality is related to baseline stability, salt residues, and analytical stability.
Precipitation/washing reagent	60-29-7	D1506340	Diethyl ether (regulated precursor chemical)	Anhydrous, ACS	Used for crude peptide precipitation and post-treatment of cleavage solutions; helps remove acids, scavengers, and small-molecule residues.
Precipitation/washing reagent	1634-04-4	B119671	Methyl tert-butyl ether (MTBE)	Anhydrous, ≥99.8%	Used for crude peptide precipitation, washing, and post-treatment; suitable for reducing the interference of cleavage residues in subsequent analysis.

Table 2. Reagents Related to Deprotection, Acid Treatment, Capping, and Side Reactions

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Acid cleavage reagent	76-05-1	T433655	Trifluoroacetic acid (TFA)	Anhydrous, ≥99%	Used for resin cleavage and removal of acid-sensitive protecting groups; relevant to troubleshooting acid-treatment side reactions, side-chain stability, and cleavage conditions.
Coupling base	7087-68-5	N433364	N-Ethyldiisopropylamine solution	Suitable for peptide synthesis, ~2 M in 1-methyl-2-pyrrolidinone	Used to adjust alkalinity and promote reactions of activated intermediates during coupling; relevant to troubleshooting coupling efficiency, racemization risk, and the influence of residual base.
Capping reagent	108-24-7	A1506320	Acetic anhydride (regulated precursor chemical)	European Pharmacopoeia (Ph. Eur.), puriss. p.a., ISO, ACS, ≥99% (GC)	Used for capping unreacted amino groups; relevant to troubleshooting acetylated truncated peptides, non-target acetylation, and post-capping washing.
Side-reaction-related reagent	50-00-0	F111941	Formaldehyde solution	Molecular biology grade, ≥36.0% in H₂O (T), contains 10–15% methanol as stabilizer	Used to evaluate model risks of amino-group addition, imine/hydroxymethyl formation, and subsequent reductive alkylation induced by aldehyde impurities.
Coupling base	121-44-8	T103290	Triethylamine	Ultrapure, ≥99.5% (GC)	Used to neutralize acidic components and adjust reaction alkalinity; relevant to activation efficiency, residual base, and side-reaction control.
Side-reaction marker	124-40-3	D110990	Dimethylamine (DMA)	Moligand™, standard for GC, 40% in water	Relevant to troubleshooting solvent degradation and protecting-group stability; can be used to analyze the effect of aged DMF on deprotection and impurity formation.
Acidic additive	64-19-7	A116167	Glacial acetic acid	Moligand™, ≥99.8%	Used for acidic condition adjustment and analytical system optimization; relevant to troubleshooting mobile-phase acidity, peak shape, sample stability, and liquid chromatography methods.
Acylation-related reagent	75-36-5	A108662	Acetyl chloride	AR, ≥98%	Used for acetylation reaction studies; can be used to establish acetylated impurity references and verify amino-group acylation reactions.
Acidic additive	64-18-6	F100377	Anhydrous formic acid (FA)	AR, ≥98%	Used in liquid chromatography and mass spectrometry systems; relevant to troubleshooting mobile-phase acidity, sample storage stability, and impurity changes after purification. Formylation assessment should be combined with activation/dehydration conditions, temperature, and storage time.
Coupling base	109-02-4	M104642	N-Methylmorpholine	≥99% (GC)	Used for peptide coupling and adjustment of reaction alkalinity; relevant to activation-system selection, coupling efficiency, and observation of side-reaction levels.
Deprotection base	6674-22-2	D106478	1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU)	≥99%	Used in strong-basic deprotection and special deprotection systems; relevant to deprotection rate, base-sensitive sequences, and side-reaction troubleshooting.
Deprotection reagent	110-89-4	P1506303	Piperidine (regulated precursor chemical)	≥99%	Used for fluorenylmethoxycarbonyl deprotection; relevant to troubleshooting incomplete deprotection, dibenzofulvene capture, and washing residues.
Deprotection reagent	626-58-4	M158650	4-Methylpiperidine	≥98% (GC)	Used as an alternative system for fluorenylmethoxycarbonyl deprotection; suitable for comparing deprotection efficiency and differences in byproduct residues.
Acylation-related reagent	407-25-0	T104827	Trifluoroacetic anhydride (TFAA)	≥98%	Used for trifluoroacetylation reaction studies; can be used to establish trifluoroacetylated impurity references and verify amino-group acylation risk.
Deprotection byproduct	4425-82-5	M694615	9-Methylene-9H-fluorene	≥97%	A byproduct related to fluorenylmethoxycarbonyl deprotection; used to study deprotection byproduct residues, adduct formation, and abnormal alkylation risk.

Table 3. Coupling Reagents and Coupling Additives

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Carbodiimide coupling reagent	538-75-0	D432856	N,N′-Dicyclohexylcarbodiimide solution	1.0 M in methylene chloride	Used for carboxyl activation and amide-bond formation; relevant to troubleshooting incomplete coupling, urea byproducts, and deletion peptides.
Carbodiimide coupling reagent	693-13-0	N420184	N,N′-Diisopropylcarbodiimide (DIC)	≥98.5%	Used for solid-phase peptide coupling reactions; relevant to coupling efficiency, activation-related side reactions, and removal of residual reagents.
Carbodiimide coupling reagent	25952-53-8	E106172	1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride	≥98%	Used for carboxyl activation and amide-bond construction; suitable for solution-phase coupling, control synthesis, and analysis of deletion peptide sources.
Uronium salt coupling reagent	148893-10-1	H109327	O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU)	≥99%	Used for coupling difficult sites and sterically hindered sequences; relevant to deletion peptides, racemization, and coupling-condition screening.
Uronium salt coupling reagent	94790-37-1	H106174	Benzotriazol-1-yloxy-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU)	≥99%	Used for routine peptide-bond coupling; relevant to coupling efficiency, the influence of benzotriazole-type additives, and deletion-sequence troubleshooting.
Uronium salt coupling reagent	330645-87-9	C106175	6-Chlorobenzotriazol-1-yloxy-N,N,N′,N′-tetramethyluronium hexafluorophosphate	≥98%	Used for peptide-bond coupling in chlorobenzotriazole systems; suitable for comparing activation ability, coupling completion, and side-reaction differences.
Uronium salt coupling reagent	125700-67-6	T109338	O-Benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium tetrafluoroborate	≥98%	Used for peptide coupling reactions; relevant to activation-system selection, deletion peptide control, and observation of batch stability.
Phosphonium salt coupling reagent	128625-52-5	P109336	Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate	≥98%	Used for peptide-bond coupling and difficult fragment synthesis; relevant to incomplete coupling, sequence aggregation, and byproduct troubleshooting.
Phosphonium salt coupling reagent	156311-83-0	A109335	7-Azabenzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate	≥97%	Used for peptide-bond coupling in azabenzotriazole systems; suitable for sterically hindered site coupling and deletion peptide control.
Coupling reagent	1075198-30-9	C340003	COMU	≥98%	Used for peptide coupling and reducing the impact of some byproducts from traditional systems; relevant to coupling-condition screening, impurity-profile comparison, and process optimization.
Coupling reagent	165534-43-0	D100524	3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4-one (DEPBT)	≥98%	Used for amide-bond construction and peptide-fragment coupling; relevant to racemization control, difficult coupling sites, and byproduct troubleshooting.
Coupling additive	39968-33-7	H109328	1-Hydroxy-7-azabenzotriazole (HOAt)	≥99%	Used to improve active ester reaction efficiency and reduce certain racemization risks; relevant to difficult coupling sites and coupling side-reaction control.
Coupling additive	2592-95-2	H684271	1-Hydroxybenzotriazole (HOBt)	≥99%	Used for active ester formation in carbodiimide coupling systems; relevant to racemization control, coupling efficiency, and deletion peptide troubleshooting.
Coupling additive	26198-19-6	C109318	6-Chloro-1-hydroxybenzotriazole	≥98%	Used in chlorobenzotriazole activation systems; suitable for comparing coupling efficiency and side-reaction differences.
Coupling additive	3849-21-6	E138773	Ethyl 2-cyano-2-(hydroxyimino)acetate	≥98%	Used in peptide coupling additive systems; relevant to coupling efficiency, activation byproducts, and deletion-sequence troubleshooting.
Active ester additive	6066-82-6	H109330	N-Hydroxysuccinimide (NHS)	≥98%	Used for active ester preparation and coupling reactions; relevant to acyl intermediate stability, coupling efficiency, and amino-group acylation troubleshooting.
Active ester additive	771-61-9	P106717	Pentafluorophenol	≥99%	Used for active ester construction and carboxyl activation studies; relevant to peptide-bond formation efficiency, active ester residues, and non-target acylation troubleshooting.

Table 4. Reagents Related to Protecting-Group Introduction and Protecting Strategies

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Amino-protecting reagent	28920-43-6	F432547	9-Fluorenylmethyl chloroformate	Suitable for synthesis	Used to introduce the fluorenylmethoxycarbonyl protecting group; relevant to deprotection efficiency, dibenzofulvene byproducts, and amino-protection strategy studies.
Amino-protecting reagent	82911-69-1	F106173	9-Fluorenylmethyl N-succinimidyl carbonate	≥98%	Used for mild introduction of the fluorenylmethoxycarbonyl protecting group; relevant to amino-protection integrity, deprotection byproducts, and sequence synthesis quality.
Amino-protecting reagent	24424-99-5	D432366	Di-tert-butyl dicarbonate solution	2 M in THF	Used to introduce the tert-butoxycarbonyl protecting group; relevant to acid-deprotection strategies, amino-protection selection, and side-reaction controls.
Amino-protecting reagent	2937-50-0	A151782	Allyl chloroformate	≥98%	Used to introduce the allyloxycarbonyl protecting group; relevant to selective deprotection, scavenger selection, and allyl-related side-reaction troubleshooting.
Amino-protecting reagent	501-53-1	B105737	Benzyl chloroformate	≥96%, contains 0.1% sodium carbonate as stabilizer	Used to introduce the benzyloxycarbonyl protecting group; relevant to amino-protection strategy, deprotection conditions, and side-chain compatibility studies.
Side-chain protecting reagent	76-83-5	T106184	Triphenylmethyl chloride	≥97%	Used for protection studies involving thiol, hydroxyl, imidazole, and other sites; relevant to side-chain protection integrity and troubleshooting acid-cleavage side reactions.
Side-chain protecting reagent	14470-28-1	M113503	4-Methoxytriphenylmethyl chloride	≥97%	Used to introduce acid-sensitive side-chain protecting groups; relevant to selective deprotection, side-chain exposure, and control of non-target modifications.

Table 5. Cleavage Scavengers and Reagents for Controlling Side-Chain Side Reactions

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Cleavage scavenger	100-66-3	A103684	Anisole	Anhydrous, ≥99.7%	Used to capture reactive intermediates in acid-cleavage systems; relevant to side-chain protecting-group removal and acid-treatment side-reaction control.
Cleavage scavenger	108-39-4	C108243	m-Cresol	Standard for GC, ≥99.7% (GC)	Used in acid cleavage and global deprotection systems; relevant to scavenging aromatic side-chain- and tert-butyl-related reactive species and controlling side reactions.
Cleavage scavenger	100-68-5	T107511	Thioanisole	≥99%	Used in acid-cleavage scavenger systems; relevant to side-reaction control for sulfur-containing, aromatic, and acid-sensitive sequences.
Cleavage scavenger	108-95-2	P128316	Phenol	≥99%	Used to capture reactive intermediates in acid-cleavage systems; relevant to protection of sensitive residues such as tyrosine and tryptophan and impurity control.
Silane scavenger	6485-79-6	T420182	Triisopropylsilane (TIS)	≥98.5%	Used to capture carbocations and protecting-group cleavage products in acid-cleavage systems; relevant to side-chain modifications after cleavage and impurity control.
Silane scavenger	617-86-7	T106570	Triethylsilane (NSC 93579)	≥98%	Used in acid cleavage and reductive scavenging systems; relevant to side-chain deprotection, reactive intermediate scavenging, and observation of cleavage side reactions.
Thiol scavenger	14970-87-7	D154345	3,6-Dioxa-1,8-octanedithiol	≥97% (GC)	Used in acid-cleavage scavenger systems; relevant to side-reaction control for cysteine, tryptophan, and acid-sensitive sequences.
Thiol scavenger	540-63-6	E106222	1,2-Ethanedithiol	≥97%	Used to capture reactive intermediates in acid-cleavage systems; relevant to protection of sulfur-containing residues, deprotection side reactions, and cleavage impurity control.

Note: The above are representative Aladdin products. For more product specifications, search by “product name/CAS/catalog number” on the Aladdin website.

References

[1] Yang Y. Side Reactions in Peptide Synthesis. Academic Press, 2015.

[2] Behrendt R, White P, Offer J. Advances in Fmoc solid-phase peptide synthesis. Journal of Peptide Science, 2016, 22(1): 4–27.

[3] Fields G B, Noble R L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. International Journal of Peptide and Protein Research, 1990, 35(3): 161–214.

[4] Coin I, Beyermann M, Bienert M. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nature Protocols, 2007, 2(12): 3247–3256.

[5] King D S, Fields C G, Fields G B. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. International Journal of Peptide and Protein Research, 1990, 36(3): 255–266.

[6] Magtaan J K, Devocelle M, Kelleher F. Regeneration of aged DMF for use in solid-phase peptide synthesis. Journal of Peptide Science, 2019, 25(1): e3139.

[7] Isidro-Llobet A, Álvarez M, Albericio F. Amino acid-protecting groups. Chemical Reviews, 2009, 109(6): 2455–2504.

[8] Chan W C, White P D. Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press, 2000.

For more related articles, see below:

A Complete Guide to Choosing Resins for SPPS (Solid-Phase Peptide Synthesis): Fmoc/Boc Routes, C-Terminal Acid/Amide, and a Key-Parameter Navigator

Suitable for peptide synthesis

Low Racemization in Peptide Synthesis Is Not Just About Reagent Choice: Stereochemical Risk During the Activation Stage and Practical Strategies for Experimental Control

From Analytical Instrument to Synthetic Platform: A New Strategy for Reconstructing Automated Flow Solid-Phase Peptide Synthesis with Standard Analytical HPLC

Silicon Reagent-Assisted Peptide Synthesis: Research Progress and Methodological Value of Peptide Bond Formation from Unprotected Substrates

Decision Logic for Peptide Synthesis Routes: Applicability and Criteria for Choosing among SPPS, LPPS, and Recombinant Expression

Low-Racemization Control in Peptide Synthesis: An Inverse N→C Peptide Synthesis Strategy via Activated α-Aminoesters

Decision Logic for Selecting Coupling Reagents in Amide Bond Formation: Activation Pathways, Side Reactions, Epimerization, Workup, and Safety